Sign In
Get Clay Free →

Suggestions

    Kenneth Keen

    Kenneth Keen is a Managing Director and Senior Partner at The Boston Consulting Group (BCG), based in the Washington, DC office.1 He has been with BCG since 2000 and has extensive experience working with healthcare and consumer companies, particularly in areas related to marketing, sales, and organization.1

    Key Responsibilities and Expertise

    Kenneth Keen's work at BCG focuses on:

    • Helping pharmaceutical and consumer health companies enhance their go-to-market and commercialization capabilities1
    • Brand and portfolio strategy
    • Launch planning
    • Life cycle management
    • Sales force organization and effectiveness

    He also has experience in pharmaceutical medical affairs and consumer health research and development.1

    Background and Experience

    Before joining BCG, Kenneth Keen spent eight years working in marketing and public relations in the pharmaceutical and biotechnology industries.1 This prior experience likely contributes to his expertise in the healthcare sector.

    Notable Contributions

    Kenneth Keen has been involved in several significant projects and initiatives at BCG:

    • Supporting more than six large-scale post-merger integrations1
    • Developing strategies to improve sales team efficiency, including the advice to "double down on your loyalists"1
    • Contributing to BCG's insights on the evolving role of medical affairs in the pharmaceutical industry1

    Kenneth Keen's work reflects BCG's focus on helping biopharmaceutical companies adapt to the changing healthcare landscape, where there is an increasing demand for positive health outcomes rather than just drugs and devices.1

    Highlights

    Apr 12 · bcg.com
    Team B Unlocks Best-in-Class Pharma Launches | BCG

    Related Questions

    What are some of Ken Keen's most notable projects at BCG?
    How has Ken Keen's experience in the pharma industry influenced his approach at BCG?
    What strategies does Ken Keen recommend for enhancing go-to-market capabilities in the pharmaceutical sector?
    How does Ken Keen's work with consumer health companies differ from his work with pharmaceutical companies?
    What are the key challenges Ken Keen has identified in the biopharmaceutical industry?
    K
    Get intro to Kenneth
    Add to my network

    Location

    Washington D.C. Metro Area